Media Report That SFDA's Zhang Jingli, Suspected Of Bribery, Might Have Received Payments From Johnson & Johnson
This article was originally published in PharmAsia News
Executive Summary
Media reports recently have stated that the case of former SFDA Deputy Commissioner Zhang Jingli, now subject to a Central Commission for Discipline Inspection bribery investigation, might have involved Shanghai Johnson & Johnson Medical and a number of other medical device companies